Establishment of the large-scale longitudinal multi-omics dataset in COVID-19 patients: data profile and biospecimen |
Jo, Hye-Yeong
(Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency)
Kim, Sang Cheol (Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Ahn, Do-hwan (Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Lee, Siyoung (Geninus Inc) Chang, Se-Hyun (Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Jung, So-Young (Division of Biobank, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Kim, Young-Jin (Division of Genome Science, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Kim, Eugene (Division of Biobank, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Kim, Jung-Eun (Division of Bio Bigdata, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Kim, Yeon-Sook (Division of Infectious Disease, Department of Internal Medicine, Chungnam National University School of Medicine) Park, Woong-Yang (Geninus Inc) Cho, Nam-Hyuk (Department of Microbiology and Immunology, College of Medicine, Seoul National University) Park, Donghyun (Geninus Inc) Lee, Ju-Hee (Division of Healthcare and Artificial Intelligence, Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) Park, Hyun-Young (Department of Precision Medicine, Korea National Institute of Health, Korea Disease Control and Prevention Agency) |
1 | Stephenson E, Reynolds G, Botting RA et al (2021) Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med 27, 904-916 DOI |
2 | Carubbi F, Salvati L, Alunno A et al (2021) Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units. Sci Rep 11, 4863 |
3 | Chakurkar V, Rajapurkar M, Lele S et al (2021) Increased serum catalytic iron may mediate tissue injury and death in patients with COVID-19. Sci Rep 11, 19618 |
4 | Biamonte F, Botta C, Mazzitelli M et al (2021) Combined lymphocyte/monocyte count, D-dimer and iron status predict COVID-19 course and outcome in a long-term care facility. J Transl Med 19, 79 |
5 | Ling L, Chen Z, Lui G et al (2021) Longitudinal cytokine profile in patients with mild to critical COVID-19. Front Immunol 12, 763292 |
6 | Kwok AJ, Mentzer A and Knight JC (2021) Host genetics and infectious disease: new tools, insights and translational opportunities. Nat Rev Genet 22, 137-153 DOI |
7 | Delorey TM, Ziegler CGK, Heimberg G et al (2021) COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107-113 DOI |
8 | Huang SF, Huang YC, Chang FY et al (2020) Rapid establishment of a COVID-19 biobank in NHRI by National Biobank Consortium of Taiwan. Biomed J 43, 314-317 DOI |
9 | Deng H, Yan X and Yuan L (2021) Human genetic basis of coronavirus disease 2019. Signal Transduct Target Ther 6, 344 |
10 | Park HJ, Kim YJ, Kim DH et al (2016) HLA allele frequencies in 5802 Koreans: varied allele types associated with SJS/TEN according to culprit drugs. Yonsei Med J 57, 118-126 DOI |
11 | Barquera R, Collen E, Di D et al (2020) Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. HLA 96, 277-298 DOI |
12 | Tomita Y, Ikeda T, Sato R and Sakagami T (2020) Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis. Immun Inflamm Dis 8, 684-694 DOI |
13 | Sakuraba A, Haider H and Sato T (2020) Population difference in allele frequency of HLA-C*05 and its correlation with COVID-19 mortality. Viruses 12, 1333 |
14 | World Health Organization (January 2020) Surveillance case definitions for human infection with novel coronavirus (nCoV): interim guidance v1. (https://apps.who.int/iris/handle/10665/330376. |
15 | Iyer M, Jayaramayya K, Subramaniam MD et al (2020) COVID-19: an update on diagnostic and therapeutic approaches. BMB Rep 53, 191-205 DOI |
16 | Rambaut A, Holmes EC, O'Toole A et al (2020) A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol 5, 1403-1407 DOI |
17 | Tian Y, Carpp LN, Miller HER, Zager M, Newell EW and Gottardo R (2022) Single-cell immunology of SARS-CoV-2 infection. Nat Biotechnol 40, 30-41 DOI |
18 | He C, Liu C, Yang J et al (2022) Prognostic significance of day-by-day in-hospital blood pressure variability in COVID-19 patients with hypertension. J Clin Hypertens (Greenwich) 24, 224-233 DOI |
19 | Alunno A, Carubbi F and Rodriguez-Carrio J (2020) Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin. RMD Open 6, e001295 |
20 | Han H, Ma Q, Li C et al (2020) Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 9, 1123-1130 DOI |
21 | Nesterenko PA, McLaughlin J, Tsai BL et al (2021) HLA-A(*)02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep 37, 110167 |
22 | Migliorini F, Torsiello E, Spiezia F, Oliva F, Tingart M and Maffulli N (2021) Association between HLA genotypes and COVID-19 susceptibility, severity and progression: a comprehensive review of the literature. Eur J Med Res 26, 84 |
23 | Kolin DA, Kulm S and Elemento O (2020) Clinical and genetic characteristics of COVID-19 patients from UK Biobank. medRxiv 2020.05.05.20075507 DOI |
24 | Maiese A, Manetti AC, La Russa R et al (2021) Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol 17, 279-296 DOI |
25 | Kayaaslan B and Guner R (2021) COVID-19 and the liver: a brief and core review. World J Hepatol 13, 2013-2023 DOI |
26 | Kolin DA, Kulm S, Christos PJ and Elemento O (2020) Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank. PLoS One 15, e0241264 |
27 | Choi H and Shin EC (2022) Hyper-inflammatory responses in COVID-19 and anti-inflammatory therapeutic approaches. BMB Rep 55, 11-19 DOI |
28 | Wei J, Stoesser N, Matthews PC et al (2021) Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol 6, 1140-1149 DOI |
29 | Khare S, Gurry C, Freitas L et al (2021) GISAID's role in pandemic response. China CDC Wkly 3, 1049-1051 DOI |
30 | Ministry of Health and Welfare (10 March 2022); https://ncov.mohw.go.kr/. |
31 | Bernardes JP, Mishra N, Tran F et al (2020) Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19. Immunity 53, 1296-1314 e1299 |
32 | Wang S, Yao X, Ma S et al (2021) A single-cell transcriptomic landscape of the lungs of patients with COVID-19. Nat Cell Biol 23, 1314-1328 DOI |
33 | Overmyer KA, Shishkova E, Miller IJ et al (2021) Large-scale multi-omic analysis of COVID-19 severity. Cell Syst 12, 23-40 e27 |
34 | Wu P, Chen D, Ding W et al (2021) The trans-omics landscape of COVID-19. Nat Commun 12, 4543 |
35 | An H, Zhang J, Li T et al (2022) Inflammation/coagulo pathy/immunology responsive index predicts poor COVID-19 prognosis. Front Cell Infect Microbiol 12, 807332 |
36 | Holub P, Kozera L, Florindi F et al (2020) BBMRI-ERIC's contributions to research and knowledge exchange on COVID-19. Eur J Hum Genet 28, 728-731 DOI |
37 | Feldstein LR, Rose EB, Horwitz SM et al (2020) Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 383, 334-346 DOI |
38 | National Institute of Health (NIH) (March 2022) Clinical spectrum of SARS-CoV-2 infection : https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ |
39 | Kappert K, Jahic A and Tauber R (2020) Assessment of serum ferritin as a biomarker in COVID-19: bystander or participant? Insights by comparison with other infectious and non-infectious diseases. Biomarkers 25, 616-625 DOI |
40 | Coronaviridae Study Group of the International Committee on Taxonomy of V (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5, 536-544 DOI |